Mumbai-based Elder Pharmaceuticals has announced the introduction of a line of over-the-counter “inhalers for nasal congestion.” The intranasal products will be sold under the Solo brand, a range of products that also includes a pain balm, cough drops, and throat lozenges. The company said that it will target rural markets with the Solo brand.
Elder Pharmaceuticals Limited Managing Director Alok Saxena commented, “Over-the-counter inhalers are the first level treatment for nasal congestion and doctors/specialists are consulted only if the condition worsens. Rising cost of raw materials, competitive market conditions and over dependency on the urban markets had affected the sales of the company’s OTC products in the recent years. With focus on price, product mix and penetration, Elder is set to regain its prime position in the OTC sector.”
Read the Elder Pharmaceuticals press release.
